Kawabata Atsufumi, Nishikawa Hiroyuki, Saitoh Hitomi, Nakaya Yumiko, Hiramatsu Kaori, Kubo Satoko, Nishida Minoru, Kawao Naoyuki, Kuroda Ryotaro, Sekiguchi Fumiko, Kinoshita Mitsuhiro, Kakehi Kazuaki, Arizono Naoki, Yamagishi Hisakazu, Kawai Kenzo
School of Pharmaceutical Sciences, Kinki University, Higashi-Osaka, Japan.
Gastroenterology. 2004 Jan;126(1):208-19. doi: 10.1053/j.gastro.2003.10.071.
On activation, protease-activated receptor (PAR)-2 modulates multiple gastric functions and exerts mucosal protection via activation of sensory neurons. The role of PAR-1, a thrombin receptor, in the stomach remains unknown. We thus examined if the PAR-1 agonist could protect against gastric mucosal injury in rats.
Gastric mucosal injury was created by oral administration of ethanol/HCl or absolute ethanol in conscious rats. Gastric mucosal blood flow and acid secretion were determined in anesthetized rats. Immunohistochemical analyses of PAR-1 and cyclooxygenase (COX)-1 were also performed in rat and human stomach.
The PAR-1 agonist TFLLR-NH(2), administered intravenously in combination with amastatin, protected against the gastric mucosal injury induced by ethanol/HCl or absolute ethanol. The protective effect of TFLLR-NH(2) was abolished by indomethacin or a COX-1 inhibitor but not by ablation of sensory neurons with capsaicin. TFLLR-NH(2) produced an NO-independent increase in gastric mucosal blood flow that was partially inhibited by blockade of the endothelium-derived hyperpolarizing factor pathway. This inhibitory effect was promoted by indomethacin. TFLLR-NH(2) suppressed carbachol-evoked acid secretion in an indomethacin-reversible manner. Immunoreactive PAR-1 and COX-1 were expressed abundantly in rat gastric muscularis mucosae and smooth muscle, and the former protein was also detectable in blood vessels. Similar staining was observed in human gastric muscularis mucosae.
The PAR-1 agonist, given systemically, protects against gastric mucosal injury via COX-1-dependent formation of prostanoids, modulating multiple gastric functions. Our data identify a novel protective role for PAR-1 in gastric mucosa, and the underlying mechanism is entirely different from that for PAR-2.
蛋白酶激活受体(PAR)-2激活后可调节多种胃功能,并通过激活感觉神经元发挥黏膜保护作用。凝血酶受体PAR-1在胃中的作用尚不清楚。因此,我们研究了PAR-1激动剂是否能保护大鼠胃黏膜免受损伤。
通过给清醒大鼠口服乙醇/盐酸或无水乙醇造成胃黏膜损伤。在麻醉大鼠中测定胃黏膜血流量和胃酸分泌。还对大鼠和人胃进行了PAR-1和环氧化酶(COX)-1的免疫组织化学分析。
PAR-1激动剂TFLLR-NH₂与抑肽酶联合静脉给药,可保护大鼠免受乙醇/盐酸或无水乙醇诱导的胃黏膜损伤。吲哚美辛或COX-1抑制剂可消除TFLLR-NH₂的保护作用,但辣椒素消融感觉神经元不能消除该作用。TFLLR-NH₂可使胃黏膜血流量非依赖一氧化氮增加,内皮源性超极化因子途径阻断可部分抑制该增加。吲哚美辛可增强这种抑制作用。TFLLR-NH₂以吲哚美辛可逆的方式抑制卡巴胆碱诱发的胃酸分泌。免疫反应性PAR-1和COX-1在大鼠胃黏膜肌层和平滑肌中大量表达,前者蛋白在血管中也可检测到。人胃黏膜肌层也观察到类似染色。
全身给予PAR-1激动剂可通过COX-1依赖性前列腺素形成保护胃黏膜免受损伤,调节多种胃功能。我们的数据确定了PAR-1在胃黏膜中的一种新的保护作用,其潜在机制与PAR-2完全不同。